Fluxion Biosciences, a privately held drug discovery tools company, announced today that it has added 4 new senior management positions and expanded sales and technical support globally. The new ...

Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in ...

Fluxion Biosciences Launches New Range of Circulating Tumor Cell (CTC) Recovery Kits- First Launch of Commercial Kits Targeting EMT Cells New kits add additional markers to improve capture efficiency ...

Fluxion Biosciences, a leading developer of microfluidic systems for functional cell analysis, today announced that it has received a $1.8 million NIH grant for the development of a high-throughput ...

Fluxion Biosciences has announced that it has signed a distribution agreement for EMD Millipore’s PrecisION® range of ion channel cell lines. The non-exclusive distribution agreement will combine ...

Fluxion Biosciences, Inc. announced a new capability to include full-service clinical sample procurement that will expand Fluxion’s IsoFlux Discovery Services offering. Fluxion currently offers a ...

Group will provide live-cell assays in response to increasing demand. Fluxion Biosciences is launching a discovery services business to support growing demand for assay support on Fluxion’s cell ...

Combination with IonFlux™ Automated Patch Clamp System creates a validated, affordable solution for ion channel profiling and screening SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Fluxion ...